Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 3.1 Exhibit 3.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.7 Exhibit 10.7
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11(B)
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19A
- 10.19 Exhibit 10.19(B)
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25A
- 10.25 Exhibit 10.25B
- 10.27 Exhibit 10.27
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
AMPH similar filings
Filing view
External links
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption "Experts" and to the use of our report dated August 20, 2004, with respect to the financial statements of Armstrong Pharmaceuticals, Inc. included in the Amendment No. 1 to the Registration Statement (Form S-1 No. 333-122725) and related Prospectus of Amphastar Pharmaceuticals, Inc. for the registration of shares of its common stock.
/s/ CARLIN, CHARRON & ROSEN LLP
Westborough, Massachusetts
May 12, 2005